LUCAT1 and non-small cell lung carcinoma: LUCAT1 dysregulation was observed in various cancers, including non-small-cell lung cancer, glioma, renal cell carcinoma, esophageal squamous cell carcinoma, prostate cancer, cutaneous squamous cell carcinoma, and CRC15–21.